Order results by:
Issue | Title | |
Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
"... to Treatment (QAA-25) and the Domestic Therapy Adherence Questionnaire (DTAQ), laboratory studies were ..." | ||
Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
N. N. Petrova | ||
"... , highlights the issues of adherence to antidepressant therapy, investigation of the safety and efficacy ..." | ||
Vol 13, No 4 (2021) | Medication adherence in migraine patients (data of an online survey) | Abstract similar documents |
N. A. Kovalchuk, E. A. Kiryanova, G. R. Tabeeva | ||
"... Patient needs, drug intake patterns, and adherence to therapy are significant challenges ..." | ||
Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
E. A. Kovalenko, A. N. Bogolepova | ||
"... Adherence to long-term medication is one of the most important components of effective therapy ..." | ||
Vol 6, No 3 (2014) | Analysis of reasons for low adherence to antiepileptic therapy in patients with symptomatic epilepsy | Abstract similar documents |
M. A. Vagina, L. I. Volkova | ||
"... Objective: to study the major factors that influence treatment adherence. Patients and methods ..." | ||
Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
Oleg Semenovich Levin, V K Datiyeva | ||
"... for higher adherence to treatment and its higher efficiency. ..." | ||
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
A. N. Boyko | ||
"... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
P. N. Vlasov | ||
"... ultimately lowers patient adherence to therapy. Pharmaceutical technologies ensuring a delayed release ..." | ||
Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
T. E. Shmidt | ||
"... of neurogenesis. The efficiency of treatment is known to be associated with patient medication adherence ..." | ||
Vol 6, No 2 (2014) | Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization | Abstract similar documents |
D.S. Danilov | ||
Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
V. A. Parfenov | ||
"... цереброваскулярного заболевания (ЦВЗ). Некоторые нелекарственные и лекарственные методы могут уменьшить проявления КН ..." | ||
Vol 9, No 1 (2017) | Combination therapy for cognitive and emotional impairments in patients with arterial hypertension | Abstract similar documents |
O. D. Ostroumova, E. A. Karavashkina | ||
"... with arterial hypertension (AH). It stresses the importance of their correction to improve adherence ..." | ||
Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
"... with citicoline is actualized, increasing adherence to therapy by prescribing a convenient form of the drug Noocil ..." | ||
Vol 6, No 2 (2014) | Posttraumatic stress disorder after stroke: rate, risk factors, approaches to prevention and treatment | Abstract similar documents |
M.A. Kutlubaev, L.R. Akhmadeeva | ||
"... in patients after stroke and their adherence to drugs for the secondary prevention of vascular diseases. PTSD ..." | ||
Vol 12, No 5 (2020) | The etiology, manifestations, and therapy of chronic cerebrovascular diseases | Abstract similar documents |
A. G. Gogoleva, V. V. Zakharov | ||
"... цереброваскулярных заболеваний (ЦВЗ), обсуждается роль артериальной гипертензии, церебральной амилоидной ангиопатии ..." | ||
Vol 10, No 1 (2018) | Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy | Abstract similar documents |
N. V. Pizova | ||
"... заболеваний (ЦВЗ) при различных распространенных соматических болезнях, таких как артериальная гипертензия ..." | ||
Vol 4, No 1 (2012) | Current approaches to therapy for chronic forms of cerebrovascular diseases | Abstract similar documents |
Maksim Alekseyevich Domashenko, M Yu Maksimova, T A Popova, M M Tanashyan | ||
"... Обсуждаются вопросы клиники и лечения хронических форм цереброваскулярных заболеваний (ЦВЗ ..." | ||
Vol 3, No 1 (2011) | Clinical experience with Neurox used in patients with cerebrovascular disease | Abstract similar documents |
N. G. Mayorova, V. A. Pavlov | ||
"... (нейрокса) в составе комплексной терапии у 32 пациентов с цереброваскулярными заболеваниями - ЦВЗ: 10 ..." | ||
Vol 14, No 1 (2022) | Kinesiotherapy and non-steroidal anti-inflammatory drugs for nonspecific lumbago | Abstract similar documents |
A. A. Golovacheva, V. A. Golovacheva, V. A. Parfenov | ||
"... patients' adherence to kinesiotherapy, relieving pain in the first days of treatment. A specific NSAID ..." | ||
Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
E. V. Yakovenko, F. A. Abbasov | ||
"... and cognitive functions, can significantly improve the quality of life of patients and their adherence ..." | ||
Vol 13, No 2 (2021) | Drug-induced (medication-induced) depression in neurology practice | Abstract similar documents |
E. Yu. Ebzeeva, O. D. Ostroumova, S. V. Batyukina, T. M. Ostroumova, A. I. Kochetkov, A. A. Kirichenko | ||
"... . Its development leads to a decrease in treatment adherence, and in some cases, to discontinuation ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
Yu. A. Starchina | ||
"... treatment (carotid endarterectomy); non-drug treatments (smoking cessation and alcohol abstinence, adherence ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention | Abstract similar documents |
L.A. Geraskina | ||
"... of cognitive impairments, which also promotes increased patient treatment adherence and improved poststroke ..." | ||
Vol 4, No 3 (2012) | The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease | Abstract similar documents |
Elena Evgenyevna Vasenina, O S Levin | ||
"... with a negative effect on the gastrointestinal tract and increases treatment adherence. Thus, there is a rise ..." | ||
Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
"... цереброваскулярным заболеваниям (ЦВЗ). Отмечено, что хроническая ишемия головного мозга (ХИГМ), или дисциркуляторная ..." | ||
Vol 14, No 5 (2022) | Emotional disorders and their therapy in chronic low back pain | Abstract similar documents |
A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova | ||
"... on dopamine reuptake, interaction with sigma receptors, low incidence of side effects, and high adherence ..." | ||
Vol 4, No 2 (2012) | Therapy for back pain syndrome | Abstract similar documents |
E Yu Solovyeva | ||
"... . To reduce the risk of adverse reactions of NSAID therapy, to enhance its adherence, and to reduce its cost ..." | ||
Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
"... of exhaustion or low mood, which negatively impact adherence and, consequently, treatment efficacy. ..." | ||
Vol 14, No 4 (2022) | Management of patients with subacute back pain: how to effectively prevent chronicity | Abstract similar documents |
V. A. Golovacheva, A. A. Golovacheva, V. A. Parfenov | ||
"... insufficient adherence to treatment and adherence to medical recommendations. Patient adherence to non-drug ..." | ||
Vol 7, No 1 (2015) | Cognitive impairments in cerebrovascular disease: What is between health and dementia? | Abstract similar documents |
A. Yu. Emelin | ||
"... распространенности как острых, так и хронических форм цереброваскулярных заболеваний (ЦВЗ). Среди разнообразных ..." | ||
Vol 15, No 4 (2023) | The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) | Abstract similar documents |
M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva | ||
"... ТМО в развитии цереброваскулярного заболевания (ЦВЗ). Необходимо продолжить изучение новых соединений ..." | ||
Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
M. V. Zamergrad, S. V. Morozova | ||
"... , as well as the design of new dosage forms that enhance patient adherence to the prescribed treatment, can ..." | ||
Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
Natalia Vladimirovna Fedorova | ||
"... increases the adherence of a patient with PD to regular treatment. Two (extended- and immediate-release ..." | ||
Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
"... To reduce the risk of developing adverse events (AEs) and increase the adherence of elderly ..." | ||
Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
A. I. Isaikin, T. I. Nasonova | ||
"... administration, provide a proven and predictable therapeutic effect, and increase treatment adherence. ..." | ||
Vol 8, No 4 (2016) | NEUROLOGICAL DISORDERS IN PATIENTS WITH HYPERTENSION AND THEIR CORRECTION | Abstract similar documents |
N. V. Vakhnina, O. V. Milovanova | ||
"... to hypertensive patients’ better adherence to long-term antihypertensive therapy, which normalizes blood pressure ..." | ||
Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
"... adherence to CI treatment using newly available dosage forms such as Noocil (240 ml bottle, oral liquid form ..." | ||
Vol 11, No 1 (2019) | Efficiency of long-term vinpocetine administration in the treatment of dizziness and associated statodynamic disorders in patients with chronic cerebrovascular insufficiency (EDELWEISS study) | Abstract similar documents |
I. N. Samartsev, S. A. Zhivolupov, Yu. S. Butakova, M. V. Morozova, I. N. Barsukov | ||
"... -point Likert scale) and increase patient adherence to the therapy performed (on the DAI). The clinically ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) | Abstract similar documents |
V. A. Parfenov | ||
"... цереброваскулярного заболевания (ЦВЗ), а страдают первичной или вторичной головной болью, головокружениями различного ..." | ||
Vol 7, No 1 (2015) | Clinical experience with L-lysine escinate for acute and chronic cerebral circulatory disorders | Abstract similar documents |
N. V. Pizova | ||
"... Цереброваскулярные заболевания (ЦВЗ) являются основными причинами инвалидизации и смертности ..." | ||
Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
A. A. Naumenko, I. S. Preobrazhenskaya | ||
"... of concomitant cardiovascular disease, the degree of apathy, adherence to the training, and the early initiation ..." | ||
Vol 9, No 2 (2017) | Optimization of the management of patients with nonspecific chronic low back pain | Abstract similar documents |
E. Yu. Kalimeeva, V. A. Parfenov | ||
"... months); adherence to the latter remained in most (71.7%) patients. Conclusion. When patients with NCLP ..." | ||
Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
"... of an original dosage form – a 240 ml bottle for oral administration, which improves adherence to long-term ..." | ||
Vol 15, No 3 (2023) | Safety and tolerability of repetitive transcranial magnetic stimulation: an analysis of over 1200 sessions | Abstract similar documents |
I. S. Bakulin, A. Kh. Zabirova, A. G. Poydasheva, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov | ||
"... remain less well understood but may affect procedure tolerance and treatment adherence. Objective ..." | ||
Vol 13, No 4 (2021) | Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety | Abstract similar documents |
E. V. Shikh, Zh. M. Sizova, M. O. Astaeva | ||
"... provides a higher patient treatment adherence. ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
"... disease-modifying therapies indicate the need for close follow-up, adherence control, and psychological ..." | ||
Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
"... patients’ adherence to therapy. ..." | ||
Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
"... patients’ adherence to therapy. ..." | ||
Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
"... УКН у пациентов с цереброваскулярными заболеваниями (ЦВЗ) в условиях реальной клинической практики ..." | ||
Vol 12, No 5 (2020) | Cognitive function dynamics in comorbid patients after angioreconstructive interventions | Abstract PDF (Eng) similar documents |
M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, E. S. Berdnikovitch, R. B. Medvedev, I. I. Titkova, A. V. Naminov, A. V. Annushkin | ||
"... (ЦВЗ) общеизвестно. Вместе с тем недостаточно освещены вопросы прогноза у коморбидных пациентов, в ..." | ||
Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
"... Хронические цереброваскулярные заболевания (ЦВЗ) и нейродегенеративные заболевания (НДЗ) являются ..." | ||
Vol 9, No 3 (2017) | Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program | Abstract similar documents |
G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva | ||
"... ) у пациентов с начальными проявлениями хронического цереброваскулярного заболевания (ЦВЗ) в ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
"... be changing the perception of adverse reactions. This will significantly increase the adherence to therapy ..." | ||
Vol 16, No 4 (2024) | Chronic neck pain and combined tension headache: a unified effective treatment approach | Abstract similar documents |
V. A. Golovacheva, A. A. Golovacheva | ||
"... , the patient experienced rapid pain relief, which contributed to adherence to recommendations to increase ..." | ||
Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
"... азота (аппарат «Тианокс») у пациентов с УКН, вызванными цереброваскулярными (ЦВЗ) и нейродегенеративными ..." | ||
Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
V. V. Kovalchuk | ||
"... COVID-19 ухудшает течение цереброваскулярных заболеваний (ЦВЗ), в том числе хронической ишемии ..." | ||
Vol 2, No 1 (2010) | EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE | Abstract similar documents |
T. V. Demin, M. V. Saikhunov, D. R. Khasanova | ||
"... is associated with the adherence to the uniform patient selection criteria and management protocols after TLT ..." | ||
Vol 14, No 3 (2022) | Combined therapy for Alzheimer's disease | Abstract similar documents |
V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina | ||
"... adherence to treatment and limited interaction with caregivers. ..." | ||
Vol 14, No 6 (2022) | Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents | Abstract similar documents |
O. D. Ostroumova, A. I. Listratov, T. M. Ostroumova, A. I. Kochetkov, D. A. Sychev | ||
"... adherence to current recommendations regarding combinations of antithrombotic drugs and protocols ..." | ||
Vol 16, No 1 (2024) | Alternative and complementary treatments for migraine | Abstract PDF (Eng) similar documents |
G. R. Tabeeva, E. G. Filatova, A. V. Amelin, V. V. Osipova, A. R. Artemenko, L. R. Akhmadeeva, E. V. Ekusheva, M. I. Koreshkina, E. R. Lebedeva, A. V. Sergeev, V. A. Golovacheva, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, Yu. E. Azimova, A. P. Rachin, V. A. Parfenov | ||
"... of treatment strategies, and they have good adherence. The basic principles and approaches of CAM ..." | ||
Vol 15 (2023): (Suppl. 1) | The place of virtual reality in the rehabilitation of patients with multiple sclerosis | Abstract similar documents |
Iu. E. Korzhova, A. A. Fuks, A. S. Klochkov, A. E. Khizhnikova, N. A. Suponeva, M. N. Zakharova | ||
"... пациентов с РС шагнула вперед. Однако по-прежнему актуальна проблема приверженности реабилитации. Методы ..." | ||
Vol 7, No 1S (2015): Special issue "Epilepsy" | Factors influencing the stigmatization of patients with epilepsy | Abstract similar documents |
I. A. Grigoryeva, L. A. Troitskaya | ||
"... their stigmatization: individual traits; activity and relations in the group; the effect of a drug and its adherence ..." | ||
Vol 4, No 2 (2012) | Secondary prevention of ischemic stroke: from recommendations to real clinical practice | Abstract similar documents |
V A Shandalin, A V Fonyakin, L A Geraskina | ||
"... приверженность пациентов медикаментозному лечению и регистрировали случаи сердечно-сосудистых осложнений ..." | ||
Vol 16, No 6 (2024) | Comorbid disorders and their possible prevention in patients with vestibular vertigo | Abstract similar documents |
O. V. Kosivtsova, Yu. A. Starchina, B. A. Shoev | ||
"... острого приступа, что позволит предотвратить развитие данных симптомов, повысить приверженность пациентов ..." | ||
Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
A. V. Obukhova | ||
"... постепенным высвобождением один раз в день упрощает схему лечения и повышает приверженность больных терапии. ..." | ||
Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
"... форме холина альфосцерата (Церпехол) для приема внутрь, которая может повысить приверженность пациентов ..." | ||
1 - 66 of 66 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)